Skip to main content
BMEA logo

BMEA · Biomea Fusion, Inc.

$1.31 +0.03 (+2.34%) At close · Jul 20
Market Cap
$94.71M
Shares
72.30M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.31 Open$1.28 Day$1.27–1.34 52W$0.87–2.99 Avg vol 30d945K Short int13.8M · 19.1% float · 14.6d Short vol36% Last earningsMay 11, 2026 DataApr 2021–Jul 2026 Filing10-Q · May 11

Up next

Next earnings call
Oct 3, 2026 Est · unconfirmed · in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 11, 2026

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Sell Momentum Strong Sentiment Bullish Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 18.7 · elevated Equity put/call 0.66
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −6%
below
Price vs 50-day avg −1%
below
RSI (14) 50
neutral
MACD trend Negative
52-week position 21%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return +11%
trailing
6-month return +3%
trailing
YTD return +6%
this year
Relative strength −4%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Accumulating
5 of 65 funds reported for Jun 30 · net +10.1K sh shares · +2 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
19.13% of float · ▼ -0.9% MoM · 14.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
65 holders — mid 3-yr range
Squeeze score 70
elevated · 0–100
Fundamentals
Strong
EPS growth +69%
Y/Y
Free cash flow $-70.7M
Balance sheet $55.8M
net cash
Quant / Vol
risk profile
Very High
Volatility 90%
annualized · 1-yr
Max drawdown −64%
past year
ATR 7.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
2 · 5 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−6% Bearish
Price vs 50-day avg
−1% Neutral
RSI (14)
50 Neutral
MACD trend
Negative Bearish
52-week position
21% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Accumulating
5 of 65 funds reported for Jun 30 · net +10.1K sh shares · +2 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
19.13% of float · ▼ -0.9% MoM · 14.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
65 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $1 Now $1 · 21% 52-wk high $3
vs 200-day avg -6% vs 50-day avg -1%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BMEA
Biomea Fusion, Inc.
this stock
$94.71M +5.6% 19.1%
ONC
BeOne Medicines Ltd.
$448.86B +2.2% +22179.2% 913.5 0.1%
VRTX
Vertex Pharmaceuticals Inc / Ma
$121.95B +6.0% +46.2% 28.5 1.9%
REGN
Regeneron Pharmaceuticals, Inc.
$70.47B -12.8% +20.8% 16.4 3.3%
ARGX
Argenx SE
$52.94B +0.6% 2.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
67
% held
34.5%
Reported
5 of 65
Top holder
FMR LLC
Held Float
View
Held by Funds
Fund positions
25
View
Short & Settlement
Short Interest Falling
Shares short
13.8M
Days to cover
14.6d
Change
-130.4K sh
View
Short Volume
Short vol %
36%
As of
Jul 21, 2026
Short Total
View
Fails to Deliver
FTD shares
280
Value
$389
As of
Jun 30, 2026
View
Off-Exchange
Off-exchange %
57.6%
Week of
May 4, 2026
Off-exch Lit
View
Financials
Financials
Net income (FY)
$-61.8M
EPS diluted
$-1.18
View
Filings
SEC Filings
Latest
Investor Event Transcript
Filed
Jun 30, 2026
This year
11
View
Proposed Sales
Value
$48.2M
Shares
1.5M
Filed
May 19, 2023
View
Exempt Offerings
Offering
$56.0M
Filed
Jan 15, 2021
View
Earnings & Events
Earnings Calls
Last call
Jun 4, 2026
View

Performance

5D 20D 120D MTD YTD
BMEA -1.5% +11.0% +3.2% -10.9% +5.7%
SPY -1.0% -0.6% +7.1% -0.6% +8.8%
vs SPY -0.6% +11.6% -4.0% -10.3% -3.2%
Key facts CIK 1840439 CUSIP 09077A106 13F (30d) 5 filings 5 filers Visit website Investor relations